Certain Ordinary Shares of Nabriva Therapeutics plc are subject to a Lock-Up Agreement Ending on 10-JAN-2021. These Ordinary Shares will be under lockup for 31 days starting from 10-DEC-2020 to 10-JAN-2021. Details: The company and subsidiaries have agreed not to issue, enter into any agreement to issue or announce the issuance or proposed issuance of any ordinary shares or ordinary share equivalents for a period of 30 days following the consummation of this offering.